Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
05/2006
05/24/2006EP1334106B1 Imidazole derivatives, production method thereof and use thereof
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1775763A Carboxyl acylamide compound and its preparing method and use
05/24/2006CN1775760A Method for preparing 2-trifluoro methyl benzimidazole
05/23/2006US7049438 Quinazoline derivatives for treatment of tumours
05/18/2006WO2006051806A1 Metal complex compound and organic electroluminescent device using same
05/18/2006WO2006050921A2 Preparation of telmisartan salts with improved solubility
05/18/2006WO2006034418A3 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof
05/18/2006WO2005118554A3 Factor viia inhibitor
05/18/2006US20060106225 N3 alkylated benzimidazole derivatives as MEK inhibitors
05/18/2006US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
05/18/2006US20060106081 Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
05/18/2006CA2585315A1 Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
05/17/2006EP1656377A1 Aminobenzimidazole derivatives
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006EP1543003B1 Imidazo¬1,2-a|pyridines
05/17/2006EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/17/2006CN1772741A Antifungal compound CO22 and its prepn process and application
05/17/2006CN1256330C Process for synthesizing benzimidazolone and its derivatives
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006US7045532 ACE-2 modulating compounds and methods of use thereof
05/16/2006US7045518 Compounds for treatment of AIDS with enzyme inhibitors
05/11/2006WO2006050509A2 Amorphous and polymorphic forms of telmisartan sodium
05/11/2006WO2006049835A2 Indole and benzimidazole derivatives
05/11/2006WO2006048750A2 Novel compounds of substituted and unsubstituted adamantyl amides
05/11/2006WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor
05/11/2006WO2005065154A3 Novel esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same
05/11/2006WO2005051317A3 Substituted imidazo ring systems and methods
05/11/2006US20060100258 Growth promotion method
05/11/2006US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
05/11/2006US20060100196 Substituted amines for the treatment of alzheimer's disease
05/11/2006CA2585735A1 Novel compounds of substituted and unsubstituted adamantyl amides
05/11/2006CA2584979A1 Indole and benzimidazole derivatives
05/11/2006CA2583694A1 Amorphous and polymorphic forms of telmisartan sodium
05/10/2006EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change
05/10/2006EP1654342A1 Reactions products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives
05/10/2006EP1654258A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
05/10/2006EP1653950A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
05/10/2006EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors
05/10/2006CN1771087A Method for preparing bisphenol catalysts and bisphenols
05/10/2006CN1255404C Process for preparing substituted imidazopyridine compound
05/10/2006CN1255386C Substituted fused heterocyclic compounds
05/10/2006CN1255364C Method for reducing N oxo-compound
05/09/2006US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents
05/09/2006US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer
05/09/2006US7040929 sulpho-benzimidazole compounds; their use enhances the adhesion of hydrophilic layers to hydrophobic supports, they have no photographically active impurities and are compatible with image-wise heating with a thermal head
05/04/2006WO2006045478A1 New indole or benzimidazole derivatives
05/04/2006WO2006013210A3 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
05/04/2006US20060094789 Alpha- and beta-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
05/04/2006US20060094770 6-[[1-phenyl-2-(4-pyridinyl)-1H-benzimidazol-6-yl]oxy]hexanoic acid methyl ester; antiinflammatory agents; microglia activators; neurodegenerative diseases
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006CA2585030A1 New indole or benzimidazole derivatives
05/03/2006EP1651626A1 Urea derivatives and their use as tyrosinkinase inhibitors
05/03/2006EP1651613A1 4,5-dihydro-imidazole as p2x7 ion channel blockers
05/03/2006EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors
05/03/2006EP1651595A2 Ubiquitin ligase inhibitors
05/03/2006EP1651214A2 Benzimidazole derivatives as mek inhibitors
05/03/2006EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
05/03/2006EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands
05/03/2006CN1768044A Process for manufacture of telmisartan
05/03/2006CN1765896A Novel preparation method of ramosetron hydrochloride
05/03/2006CN1254476C Dihydroimidazo[5,1-a]-beta-carboline derivatives, method for preparing same and use thereof as medicine
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease
04/2006
04/27/2006WO2006044648A1 Process for preparing telmisartan
04/27/2006WO2006044415A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease
04/27/2006WO2006043691A1 Target protein and target gene in drug designing and screening method
04/27/2006CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease
04/27/2006CA2581723A1 Process for preparing telmisartan
04/26/2006CN1764648A hydroxamid acid derivatives as histone deacetylase (HDAC) inhibitors
04/25/2006US7034055 2-aminoindane analogs
04/20/2006WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1
04/20/2006WO2006040635A1 Processes for the preparation of substituted sulfoxides
04/20/2006WO2006040180A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/20/2006US20060084682 e.g. 5-{2-[6-(3,4-Dichloro-phenyl)-pyridin-2-yl]-1H-benzoimidazol-5-ylmethylene}-2-thioxo-thiozolidin; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
04/20/2006US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
04/20/2006CA2583973A1 Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/19/2006EP1647548A1 Dictionic bishydrazones, dyeingcompositions containig at least one of these compounds, process of their preparation and uses thereoff
04/19/2006EP1647546A1 Novel heteroaryl derivative
04/19/2006EP1646614A2 Ophthalmic compositions for treating ocular hypertension
04/19/2006EP1481002B1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
04/19/2006EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia
04/19/2006EP1064275B2 Process for producing simvastatin and/or its derivatives
04/19/2006CN1760185A Method for preparing nitrobenzimidazole of containing fluorin
04/19/2006CN1760184A Difluoro methyl amido benzimadazoles, and preparation method
04/19/2006CN1252070C Urea substituted imidazoquinolines
04/18/2006US7030161 α-and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
04/18/2006US7030150 Benzimidazole compounds and antiviral uses thereof
04/18/2006US7030139 Compounds
04/18/2006US7030113 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/13/2006WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
04/13/2006WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
04/13/2006WO2006038738A1 Receptor function regulating agent
04/13/2006WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound
04/13/2006WO2006038606A1 Biaryl derivative
04/13/2006WO2006038587A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
04/13/2006WO2005007621A3 Ubiquitin ligase inhibitors
04/13/2006US20060079521 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
04/13/2006US20060078758 Organometallic compounds and display device employing the same
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 154